Massive Cluster of Insider Selling at Semiconductor-Equipment Maker After Call-Off of Buyout Deal, Plus Insider Trading at AT&T, Delta, More

Board Member of Strong Performing REIT Buys Shares

A member of Agree Realty Corporation (NYSE:ADC)’s Board of Directors also purchased some shares this week. John Rakolta Jr., Director of the company since August 2011, bought 12,000 shares on Wednesday at a price tag of $47.50 each. Following the recent purchase, Mr. Rakolta currently holds an aggregate of 158,484 shares.

It appears that the Board member purchased the shares via a recently-held public offering of nearly 1.82 million shares, an offering that raised around $86.2 million. The fully-integrated REIT, which is focused on owning, acquiring and developing retail properties net leased to industry leading tenants, plans to use the proceeds from the offering to reduce the amounts outstanding under its revolving credit facility, as well as to fund property acquisitions and development activity, fund working capital needs, and cover general corporate expenses. At the end of September, Agree Realty Corporation (NYSE:ADC)’s portfolio comprised 341 properties in 43 states, totaling around 6.7 million square feet of gross leasable area. The REIT’s shares have gained 39% since the beginning of the year. Driehaus Capital, founded by Richard Driehaus, acquired a 14,983-share stake in Agree Realty Corporation (NYSE:ADC) during the September quarter.

CEO of Medical Equipment Maker Keeps Buying Shares

The man in charge of Natus Medical Inc. (NASDAQ:BABY) just keeps buying more and more shares. After buying 10,000 shares in September, President and Chief Executive Officer James B. Hawkins snatched up an additional 10,000 shares on Thursday at prices varying from $38.00 to $38.60 per share. After the recent purchase, Mr. Hawkins currently holds an ownership stake of 469,725 shares.

After lowering its third quarter revenue guidance in late-September due to a decision to stop shipping some products from its Seattle facility amid a process of eliminating deficiencies in engineering and manufacturing quality processes, the provider of newborn care and neurology healthcare products and services recently provided encouraging guidance for the fourth quarter. Natus Medical Inc. (NASDAQ:BABY) said that it anticipates fourth quarter revenue in the range of $107 million-to-$109 million, which would represent a year-over-year increase of 8% at the midpoint of the guidance range. In late-September, the medical equipment maker agreed to acquire the GN Otometrics business – which manufactures hearing diagnostics and balance assessment equipment, disposables and software – from GN Stone Nord for a cash consideration of $145 million. The CEO of Natus Medical believes that “Otometrics can grow organically by 5% or more in the years ahead.” The shares of Natus Medical are down by 17% year-to-date. Fisher Asset Management reported ownership of approximately 612,000 shares of Natus Medical Inc. (NASDAQ:BABY) in its 13F filing for the third quarter.

The final page of this article will discuss fresh insider selling at two companies.